ID

40480

Description

Detecting Heart Disease Using First Pass Imaging With Gated SPECT Perfusion; ODM derived from: https://clinicaltrials.gov/show/NCT01137409

Lien

https://clinicaltrials.gov/show/NCT01137409

Mots-clés

Versions (1)
  1. 25/04/2020 25/04/2020 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

25 avril 2020

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

  • Plus récent
  • Plus ancien
  • Favori
  • Plus récent
    • Plus récent
    • Plus ancien
    • Favori

Aucun commentaire

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Ischemic Heart Disease NCT01137409

Anglais

Eligibility Ischemic Heart Disease NCT01137409

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
males and females age 18 through 80 years
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
female patients who are: surgically sterile (hysterectomy or bilateral tubule libation), at least one year post-menopausal, or have a negative pregnancy test on the day of treatment
Description

Gender | Female Sterilization | Hysterectomy | Bilateral tubal ligation | Postmenopausal state Duration | Pregnancy test negative

Type de données

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0015787
UMLS CUI [3]
C0020699
UMLS CUI [4]
C0589114
UMLS CUI [5,1]
C0232970
UMLS CUI [5,2]
C0449238
UMLS CUI [6]
C0427780
written informed consent
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patient consumed food/beverage/medication containing caffeine/methylxanthines up to 12 hours prior to infusion
Description

Food Containing Caffeine | Beverages Containing Caffeine | Pharmaceutical Preparations Containing Caffeine | Food Containing Methylxanthine | Beverages Containing Methylxanthine | Pharmaceutical Preparations Containing Methylxanthine

Type de données

boolean

Alias
UMLS CUI [1,1]
C0016452
UMLS CUI [1,2]
C0332256
UMLS CUI [1,3]
C0006644
UMLS CUI [2,1]
C0005329
UMLS CUI [2,2]
C0332256
UMLS CUI [2,3]
C0006644
UMLS CUI [3,1]
C0013227
UMLS CUI [3,2]
C0332256
UMLS CUI [3,3]
C0006644
UMLS CUI [4,1]
C0016452
UMLS CUI [4,2]
C0332256
UMLS CUI [4,3]
C0066447
UMLS CUI [5,1]
C0005329
UMLS CUI [5,2]
C0332256
UMLS CUI [5,3]
C0066447
UMLS CUI [6,1]
C0013227
UMLS CUI [6,2]
C0332256
UMLS CUI [6,3]
C0066447
exacerbation of copd, asthma (actively wheezing)
Description

COPD exacerbation | Asthma | Wheezing

Type de données

boolean

Alias
UMLS CUI [1]
C0740304
UMLS CUI [2]
C0004096
UMLS CUI [3]
C0043144
sinus node dysfunction in absence of pacemaker
Description

Sinus Node Dysfunction | Artificial cardiac pacemaker Absent

Type de données

boolean

Alias
UMLS CUI [1]
C0428908
UMLS CUI [2,1]
C0030163
UMLS CUI [2,2]
C0332197
use of aggrenox (asa/dipyridamole), pentoxifylline (trental) , or oral dipyridamole (persantine)
Description

Aggrenox | Aspirin | Dipyridamole | Pentoxifylline | Trental | Dipyridamole Oral [Persantine]

Type de données

boolean

Alias
UMLS CUI [1]
C0732282
UMLS CUI [2]
C0004057
UMLS CUI [3]
C0012582
UMLS CUI [4]
C0030899
UMLS CUI [5]
C0699487
UMLS CUI [6]
C1242076
atrial fibrillation
Description

Atrial Fibrillation

Type de données

boolean

Alias
UMLS CUI [1]
C0004238
pregnant/breast feeding
Description

Pregnancy | Breast Feeding

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
non english speaking patients
Description

Lacking Able to speak English Language

Type de données

boolean

Alias
UMLS CUI [1,1]
C0332268
UMLS CUI [1,2]
C0564215
UMLS CUI [1,3]
C0376245
subject is allergic or intolerant to aminophylline, regadenoson
Description

Aminophylline allergy | Intolerance to Aminophylline | Hypersensitivity Regadenoson | Intolerance to Regadenoson

Type de données

boolean

Alias
UMLS CUI [1]
C0571074
UMLS CUI [2,1]
C1744706
UMLS CUI [2,2]
C0002575
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C1698215
UMLS CUI [4,1]
C1744706
UMLS CUI [4,2]
C1698215
subject has a history of known or suspected bronchospastic lung disease [e.g., asthma, wheezing, chronic obstructive pulmonary disease (copd, etc.)]
Description

Lung disease Bronchial Spasm | Bronchial Spasm Suspected | Asthma | Wheezing | Chronic Obstructive Airway Disease

Type de données

boolean

Alias
UMLS CUI [1,1]
C0024115
UMLS CUI [1,2]
C0006266
UMLS CUI [2,1]
C0006266
UMLS CUI [2,2]
C0750491
UMLS CUI [3]
C0004096
UMLS CUI [4]
C0043144
UMLS CUI [5]
C0024117
patients with first degree or second degree av block
Description

First degree atrioventricular block | Second degree atrioventricular block

Type de données

boolean

Alias
UMLS CUI [1]
C0085614
UMLS CUI [2]
C0264906
Retour au début de la page

Similar models

Eligibility Ischemic Heart Disease NCT01137409

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
males and females age 18 through 80 years
boolean
C0001779 (UMLS CUI [1])
Gender | Female Sterilization | Hysterectomy | Bilateral tubal ligation | Postmenopausal state Duration | Pregnancy test negative
Item
female patients who are: surgically sterile (hysterectomy or bilateral tubule libation), at least one year post-menopausal, or have a negative pregnancy test on the day of treatment
boolean
C0079399 (UMLS CUI [1])
C0015787 (UMLS CUI [2])
C0020699 (UMLS CUI [3])
C0589114 (UMLS CUI [4])
C0232970 (UMLS CUI [5,1])
C0449238 (UMLS CUI [5,2])
C0427780 (UMLS CUI [6])
Informed Consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Food Containing Caffeine | Beverages Containing Caffeine | Pharmaceutical Preparations Containing Caffeine | Food Containing Methylxanthine | Beverages Containing Methylxanthine | Pharmaceutical Preparations Containing Methylxanthine
Item
patient consumed food/beverage/medication containing caffeine/methylxanthines up to 12 hours prior to infusion
boolean
C0016452 (UMLS CUI [1,1])
C0332256 (UMLS CUI [1,2])
C0006644 (UMLS CUI [1,3])
C0005329 (UMLS CUI [2,1])
C0332256 (UMLS CUI [2,2])
C0006644 (UMLS CUI [2,3])
C0013227 (UMLS CUI [3,1])
C0332256 (UMLS CUI [3,2])
C0006644 (UMLS CUI [3,3])
C0016452 (UMLS CUI [4,1])
C0332256 (UMLS CUI [4,2])
C0066447 (UMLS CUI [4,3])
C0005329 (UMLS CUI [5,1])
C0332256 (UMLS CUI [5,2])
C0066447 (UMLS CUI [5,3])
C0013227 (UMLS CUI [6,1])
C0332256 (UMLS CUI [6,2])
C0066447 (UMLS CUI [6,3])
COPD exacerbation | Asthma | Wheezing
Item
exacerbation of copd, asthma (actively wheezing)
boolean
C0740304 (UMLS CUI [1])
C0004096 (UMLS CUI [2])
C0043144 (UMLS CUI [3])
Sinus Node Dysfunction | Artificial cardiac pacemaker Absent
Item
sinus node dysfunction in absence of pacemaker
boolean
C0428908 (UMLS CUI [1])
C0030163 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Aggrenox | Aspirin | Dipyridamole | Pentoxifylline | Trental | Dipyridamole Oral [Persantine]
Item
use of aggrenox (asa/dipyridamole), pentoxifylline (trental) , or oral dipyridamole (persantine)
boolean
C0732282 (UMLS CUI [1])
C0004057 (UMLS CUI [2])
C0012582 (UMLS CUI [3])
C0030899 (UMLS CUI [4])
C0699487 (UMLS CUI [5])
C1242076 (UMLS CUI [6])
Atrial Fibrillation
Item
atrial fibrillation
boolean
C0004238 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnant/breast feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Lacking Able to speak English Language
Item
non english speaking patients
boolean
C0332268 (UMLS CUI [1,1])
C0564215 (UMLS CUI [1,2])
C0376245 (UMLS CUI [1,3])
Aminophylline allergy | Intolerance to Aminophylline | Hypersensitivity Regadenoson | Intolerance to Regadenoson
Item
subject is allergic or intolerant to aminophylline, regadenoson
boolean
C0571074 (UMLS CUI [1])
C1744706 (UMLS CUI [2,1])
C0002575 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C1698215 (UMLS CUI [3,2])
C1744706 (UMLS CUI [4,1])
C1698215 (UMLS CUI [4,2])
Lung disease Bronchial Spasm | Bronchial Spasm Suspected | Asthma | Wheezing | Chronic Obstructive Airway Disease
Item
subject has a history of known or suspected bronchospastic lung disease [e.g., asthma, wheezing, chronic obstructive pulmonary disease (copd, etc.)]
boolean
C0024115 (UMLS CUI [1,1])
C0006266 (UMLS CUI [1,2])
C0006266 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])
C0004096 (UMLS CUI [3])
C0043144 (UMLS CUI [4])
C0024117 (UMLS CUI [5])
First degree atrioventricular block | Second degree atrioventricular block
Item
patients with first degree or second degree av block
boolean
C0085614 (UMLS CUI [1])
C0264906 (UMLS CUI [2])
Retour au début de la page 

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial